Bowen Sui

机构：First Affiliated Hospital of Heilongjiang University of Chinese Medicine · ORCID：0000-0002-8452-3954

发表论文 12 篇 · 总被引 105 次 · h-index 5

代表论文

• Triptolide suppresses paraquat induced idiopathic pulmonary fibrosis by inhibiting TGFB1-dependent epithelial mesenchymal transition (2017 · Toxicology Letters · 被引 51)
• Role of post-translational modifications of Sp1 in cancer: state of the art (2024 · Frontiers in Cell and Developmental Biology · 被引 18)
• Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants (2024 · International Reviews of Immunology · 被引 13)
• The Effect of Terpenoid Natural Chinese Medicine Molecular Compound on Lung Cancer Treatment (2021 · Evidence-based Complementary and Alternative Medicine · 被引 9)
• Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics (2021 · Journal of Healthcare Engineering · 被引 8)
• The cGAS-STING pathway in the tumor immune microenvironment: Multidimensional regulation and therapeutic implications (2026 · Critical Reviews in Oncology/Hematology · 被引 2)